CRVS EBITDA Growth
Corvus Pharmaceuticals Inc · EBITDA Growth
CRVS EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-14.38%period ending
CRVS TTM EBITDA YoY % (-85.48% → -14.38%)
Year-over-year change
High-resolution chart · PNG
CRVS ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -14.3774% | |
| -2.3163% | |
| 75.6012% | |
| 73.6059% | |
| -100.0666% | |
| -66.9968% | |
| -131.4458% | |
| -89.2911% | |
| 41.8874% | |
| 38.9829% | |
| 34.3478% | |
| 25.718% | |
| -7.1109% | |
| -2.5728% | |
| 4.0431% | |
| 6.7349% | |
| 14.7155% | |
| 4.4939% | |
| 1.0735% | |
| 3.0887% | |
| 8.3501% | |
| 15.6652% | |
| 10.3573% | |
| 6.6901% | |
| 2.4578% | |
| -6.5293% | |
| 0.5457% | |
| 3.0535% | |
| 7.2802% | |
| 14.8353% | |
| 13.1227% | |
| 9.9001% | |
| 2.2822% | |
| -17.4017% | |
| -53.044% | |
| -297.9441% | |
| -703.946% | |
| -35,617.8295% | |
| -1,014.6053% | |
| -85.478% |